GBM AGILE adaptive clinical trial is open and currently enrolling patients. If you’d like to find a trial near you, please visit clinicaltrials.gov and use the trial identifier number–NCT03970447. or click here.
If you have questions regarding GBM AGILE please contact Hali Hartmann, Director of Scientific Relations at email@example.com or 1-800-321-CURE (2873).
The support of our donors is crucial to the continued success of GBM AGILE. If you’d like to be a part of our movement to save the lives of those diagnosed with GBM, please consider a gift to GBM AGILE today. Charitable support can be made by check, credit card, stocks, IRA transfers and through donor advised funds, private foundations and charitable trusts.